|
|
13.06.25 - 10:03
|
Borregaard ASA: Change in Group Executive Management (GlobeNewswire EN)
|
|
Knut-Harald Bakke has been appointed EVP BioSolutions, effective 1 August 2025. He will also join the Group Executive Management on the same date. Bakke succeeds Tom Erik Foss-Jacobsen, who will assume the role of CEO on 1 August (see stock exchange release dated 23 May 2025)....
|
|
|
|
30.04.25 - 07:03
|
Borregaard ASA: EBITDA1 of NOK 511 million in the 1st quarter (GlobeNewswire EN)
|
|
Borregaard's operating revenues increased to NOK 2,036 million (NOK 1,975 million)2 in the 1st quarter of 2025. EBITDA1 reached NOK 511 million (NOK 442 million). The result in BioSolutions increased, BioMaterials had a result in line with the corresponding quarter last year and Fine Chemicals had a lower result....
|
|
|
|
|
|
|
09.04.25 - 23:42
|
XFRA: DIVIDEND/INTEREST INFORMATION - 11.04.2025 - NO0010657505 (XETRA)
|
|
Das Instrument BO4 NO0010657505 BORREGAARD ASA EQUITY wird cum Dividende/Zinsen gehandelt am 10.04.2025 und ex Dividende/Zinsen am 11.04.2025
The instrument BO4 NO0010657505 BORREGAARD ASA EQUITY has its pre-dividend/interest day on 10.04.2025 and its ex-dividend/interest day on 11.04.2025...
|
|
|
21.03.25 - 09:54
|
Borregaard ASA: Proxies for the Annual General Meeting 10 April 2025 (GlobeNewswire EN)
|
|
In connection with Borregaard's Annual General Meeting, Mr. Helge Aasen, Chair of the Board of Directors in Borregaard ASA, has been assigned voting rights based on proxies for 7,137,969 shares in Borregaard ASA. The proxies apply exclusively to the Annual General Meeting in Borregaard ASA on 10 April 2025. This means that Mr. Helge Aasen represents a total of 7,14 % of the outstanding shares in Borregaard ASA....
|
|
|
|
|
17.03.25 - 14:06
|
Borregaard ASA: Borregaard to participate in Alginor capital raise (GlobeNewswire EN)
|
|
Borregaard will co-invest with existing shareholders, Must Invest and Hatteland Group, in a direct offering of new shares in Alginor, amounting to NOK 100 million. Additionally, the same three shareholders will underwrite a subsequent rights issue for NOK 50 million, with subscription rights extended to all other shareholders. In total, Alginor will raise NOK 150 million in new equity. ...
|
|
|
|
|